Rating History for AN2 Therapeutics (ANTX) by Leerink

More Stocks Rated by Leerink | Latest Ratings for ANTX
Date Analyst Type Rating
(Past)		 PT
(Past)		 Start $
(End $)		 % Chg. Details
5/14/2026 Joseph Schwartz Upgrade Outperform
(Market Perform)		 9.00
(N/A)		 4.31
(4.98)		 15.55% Details